Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Jun 15:2017:bcr2016218912.
doi: 10.1136/bcr-2016-218912.

Fingolimod-associated macular oedema

Affiliations
Case Reports

Fingolimod-associated macular oedema

Kirti Madhukar Jasani et al. BMJ Case Rep. .
No abstract available

Keywords: Drug interactions; Macula; Multiple sclerosis; Neurology (drugs and medicines); Unwanted effects / adverse reactions.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Colour fundus and SPECTRALIS Spectral domain optical coherence tomography (OCT) across the right eye macula taken on presentation showing intraretinal cystic fluid spaces indicating macula oedema.
Figure 2
Figure 2
Colour fundus and SPECTRALIS Spectral domain optical coherence tomography (OCT) taken on the same axis 4 months later showing the macula oedema having resolved.

References

    1. Chun J, Hartung HP. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol 2010;33:91–101.10.1097/WNF.0b013e3181cbf825 - DOI - PMC - PubMed
    1. Moosavi R, Bremner F, Acheson J. LETTER TO THE EDITOR screening for fingolimod associated macular oedema: experience versus guidelines. Open Ophthalmol J 2014;8:73–4.10.2174/1874364101408010073 - DOI - PMC - PubMed
    1. Chui J, Herkes GK, Chang A. Management of fingolimod-associated macular edema. JAMA Ophthalmol 2013;131:694–6.10.1001/jamaophthalmol.2013.47 - DOI - PubMed

Publication types

MeSH terms